chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I have been extraordinarily careful to avoid Covid. On 5/12, I flew for a funeral. I attended a large funeral on 5/14. On 5/15 I also attended a smaller family gathering. On 5/16, I went out to eat with my husband for lunch and to dinner with my husband and daughter. Although I was in first class, I was very uncomfortable flying home and felt sore on 5/17 but I attributed it to travel and stress. I was off of work on 5/18 but wasn't feeling great. When I returned to work on 5/19, I was still not feeling well and took an at home test for Covid which was positive. I visited my doctor's office that afternoon and was prescribed Paxlovid which I began that night. By 5/22 my symptoms were basically gone and I returned after my normal isolation period. I was testing negative for Covid by 5/25 and 5/26. By 5/28 I was feeling badly again so I tested again and was positive. I saw my doctor on 5/29. I woke up this morning with a 100 degree fever and my doctor prescribed an antibiotic. I've also been taking over the counter medication to treat symptoms.
Fever, chest pain, chills, headache. Took Tylenol. All symptoms have resolved.
It was reported that a patient 2 of 4 received a Rabies Imovax ID vaccination. Reportedly 24 hours following immunization the pt developed swelling of the arm, malaise and flu-like symptoms. Further information requested.
After receiving the vaccination I experienced chest tightness, wheezing and congestion. Also a fever of 101.6 and congestion.
08/22/2010 awoke with occipital headache, stiff neck, right side of neck large swollen lymph node, some discomfort of neck.  Took pain/anti-inflamitory med. Did not help head ache. Area of injection was right deltoid, c/o swelling entirely around right upper arm. 8/24 eve. noted a rash 2 inches x 4 inches on right deltoid. Took Benadryl. Symptom disappeared by next morning. 08/26/2010 was seen by primary physician. Dx: reaction from pertussis, Rx Darvon for headache.  08/27/2010 went home from work ill; c/o headache, dizzy, blurred vision, uncoordination of movement. Rested at home. 08/28/2010 felt better and improved the next day as well. Heacache continued until 09/03/2010. Today, 09/08/2010 is feeling good--no symptoms.
I received the Janssen shot at 1 pm on the 8th of April, 2021. By 11:00 pm I was in a lot of pain all over my body especially in my bones. My stomach hurt, I was nauseated. I went through hot & cold sweats & chills. I got really light headed & disoriented. I began to get a fever.  I felt far from flu symptoms. My heart was racing. I had to get into my shower repeatedly & just lay. I cried. I dont recommend this to anyone! It has been 2 days & i am still experiencing symptoms. I read the fact sheet for the Janssen shot. I am going to get a check up by a doctor. I feel like I am having an allergic reaction. I never felt so much pain in my life; my side effects are far from the flu symptoms.
On initial shot, felt very spacey and out of it , I had to sit down for a while . A few hours after felt shortness of breathe . Blurred vision. Was unable to sleep full night , woke up with brain fog , tinnitus ,. Following day terrible brain fog , tinnitus, shortness of breathe even when laying down . Doctor recommended 36 hours later to go to ER. Went to ER- did tons of tests and cat scan of chest and x ray. No negative scans . Discharged me with no remedy , doctor confirmed adverse reaction. On the 4th day today, tinnitus has gotten worse . Mental brain fog worse . Cannot sleep. Do not feel like myself . Feel depressed , like a cloud is following me in my head .cannot remember things . Brain is not processing and functioning normally . Ringing won?t stop. Feel like I am losing my mind . Shortness of breathe is slowly getting better , but still very prevalent .
Pt had right shoulder pain with minimal range of motion; pt took APAP and NSAIDS  and tried to keep moving it .  Did not seek treatment or discuss with MD.  Pain lasted almost 4 weeks.  Pt reported the pain in her right arm due to SHINGRIX, but our records indicate she received Moderna in the right arm that day.
Severe chills; pain at injection site began at night and lasted until morning. All of the next day, fatigue and weakness. Following evening, fever of 100.9
fatigue; headache; body aches; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from a sales representative. The reporter is the patient.  A 48-year-old female patient received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation; influenza vaccine (FLU VACCINE VII), (Batch/Lot number: unknown). The patient's relevant medical history and concomitant medications were not reported. The following information was reported: FATIGUE (non-serious), outcome "unknown"; HEADACHE (non-serious), outcome "unknown"; PAIN (non-serious), outcome "unknown", described as "body aches".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Depression; This is a spontaneous report from a contactable consumer or other non hcp.  A 81-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: was not reported; Expiry Date of COVID Vaccine: unknown), dose 1 via an unspecified route of administration on an unspecified date as dose 1, single for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported.  The patient experienced depression on an unspecified date.  It was reported that the patient got into depression and she didn't go to take her second dose; it's been 90 days since she took the first dose. Reporter seriousness for the event was unspecified. The patient denied to answer any question when asked about batch number.  The patient called, her initial question was about her mother who live in withheld (Further clarification was unknown, hence COI was captured as withheld by default), was instructed to take the second vaccine 3 months later. She said that she received the vaccine 90 days ago and reported that, she received the Pfizer COVID Vaccine 90 days ago and she was instructed to come back it's been 3 months to receive the second vaccine and she was calling from (privacy). The patient said she did not go for second dose and asked what she should do and if not taking the second dose would work. She reported she got into depression, not because of the vaccine in unclear words. She reported as 90 days was crossed from the first dose can she take the second dose and would she be protected. She said that she read something that stated that it was supposed to take maximum 42 days after first dose. She was frustrated with the calls being on hold and transferred. She wanted the answer if the second dose after 90 days would protect her. She asked to transfer her call to someone who could respond to her query. Outcome of the event was unknown.  Follow-up activities closed. Batch/lot number not available.
Information has been received from a licensed practical nurse concerning a 68 year old female patient who on 30-SEP-2009 was vaccinated with a dose of PNEUMOVAX 23 (Lot # 662841/0626Y) SC, left arm. Concomitant vaccination on the same day included a dose of FLUZONE (lot # U3195AA) IM, right deltoid. Subsequently, on 01-OCT-2009 the patient's left arm was red with a warm area at the injection site. The patient was told to apply cold pack and to take CLARITIN. At the time of the report, the patient recovered on an unspecified date. It was noted that the patient could not take BENADRYL. Additional information is not expected.
Chest pressure, supraventricular tachycardia with heart rate in 160s and NSTEMI without EKG changes.
Severe headache; body aches,; joint aches; chills; nausea; This is a spontaneous report from other HCP (patient).   A 48-years-old non-pregnant female patient started to receive BNT162b2 (BNT162b2, Formulation: Solution for injection, Batch/lot number: 0000, Expiration date was not reported)(at the age of  48-years-old ), via an unspecified route in the Arm left on 03Mar2021 at 11:15, as 2 ND DOSE, SINGLE, for COVID-19 immunisation.  The patient medical history was not reported.  The patient received first dose on 10Feb2021. The patient was not tested for COVID-19.The patient was not diagnosed with COVID-19 prior to vaccination. Concomitant medications included Esomeprazole sodium (NEXIUM), Ibuprofen ,taken for an unknown indication from an unknown date to unknown if ongoing. No known allergies. On 04Mar2021 at 04:00, the patient experienced Severe headache & body aches, joint aches, chills, nausea. The patient did not receive any treatment for these events.  All the events were non-serious. The outcome of all the events were recovering.   No follow-up attempts are possible. No further information is expected.
Fever of about 100.7 degree Fahrenheit; Slept all day yesterday / had to force herself to stay awake today; "felt puffy" / the body had a "swelling sensation"; Neuropathic pain; Felt like needles were at the bottom of the feet; Felt sluggish; Tired, extreme fatigue; Muscle pain; Body and/or arthritic pain; Body and/or arthritic pain; Increased in sensitivity; Her overall entire body does not feel that great/ feeling "knocked down"; This case was reported by a consumer via call center representative and described the occurrence of feeling swollen in a 54-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Concurrent medical conditions included rheumatoid arthritis. Concomitant products included methotrexate.   On 4th January 2021, the patient received the 2nd dose of Shingrix (intramuscular). On 4th January 2021, 2 hrs after receiving Shingrix, the patient experienced feeling swollen, neuropathic pain, pins and needles, sluggishness, tiredness, muscle pain, arthritic pains, general body pain and hyperesthesia. On 5th January 2021, the patient experienced fever and sleepiness. In January 2021, the patient experienced feeling unwell. On an unknown date, the outcome of the feeling swollen, neuropathic pain, pins and needles, sluggishness, tiredness, muscle pain, arthritic pains, general body pain, hyperesthesia, sleepiness and feeling unwell were recovering/resolving and the outcome of the fever was recovered/resolved.   It was unknown if the reporter considered the feeling swollen, neuropathic pain, pins and needles, sluggishness, tiredness, muscle pain, arthritic pains, general body pain, hyperesthesia, fever, sleepiness and feeling unwell to be related to Shingrix.  Additional details were provided as follows: The reporter was patient's husband. The patient took her dose of methotrexate (7 tablets) for rheumatoid arthritis the same day of vaccination before bed.  The patient had received the 2nd dose of the Shingrix vaccine on past Monday night, at around 6pm at the left upper arm. After 2 hours of vaccination, the patient felt puffy and the body had a swelling sensation. She also experienced neuropathic pain, where it felt like needles were at the bottom of the feet, felt sluggish, tired, extreme fatigue, muscle pain, body and or arthritic pain, and an increase in sensitivity. The day after receiving the vaccine, the patient started running a fever of about 100.7 that lasted for a few hours but had since resolved. The patient slept all day on the day before reporting date, and had to force herself to stay awake on the reporting date. The patient's overall entire body did not feel that great. All other events other than fever were still ongoing till the time of reporting, but had improved since the first day. The patient did not have nausea or diarrhea.  The reporter stated that they were mainly concerned about the tiredness and feeling of "knocked down."  Not all information was available. The reporter consented to follow-up and gave permission to follow-up with healh care professional, and provided the contact information.
Father reports 10/10/14 R leg would bend when standing, unable to bear weight. 10/13/14 to urgent care R leg x-ray done. Father told x-ray WNL - ortho recommended if persists. Ortho appt not pursued.
Administered vaccine that was stored at temperature between -80 degree F to -84 degree F; Administered vaccine that was stored at temperature between -80 degree F to -84 degree F; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT STORAGE ERROR (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F) and POOR QUALITY PRODUCT ADMINISTERED (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 076C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Nov-2021 at 3:39 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 19-Nov-2021, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F). At the time of the report, PRODUCT STORAGE ERROR (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F) and POOR QUALITY PRODUCT ADMINISTERED (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication information was provided.  The vial undergone temperature excursions for 1 month. The vial was in frozen state at the time of the excursion (Vials in question stored in a super cold Freezer) and minimum reached temperatures was negative 82 degrees Fahrenheit. The patient was given dose from vial that was stored in an ultracold freezer which was colder than it should have been. The vial was moved from freezer to refrigerator on 19-Nov-2021, when the Moderna Covid-19 vials went from the super cold freezer to the refrigerator. The vials were returned to the freezer/refrigerator or maintained at room temperature.  The reporter stated that total 70 vials were still in the ultra-cold freezer and 8 vials were in the refrigerator. No vaccine state changes were noticed. The vaccine was never refrozen. None of the vials were punctured. No previous temperature excursions were reported. Total 280 patients received Moderna Covid 19 stored at minus 82 degrees Fahrenheit.  No treatment medications were provided.   This case was linked to MOD-2021-402935 (Patient Link).
At 12:02 patient complained about slight tingling to his left arm. Vital signs WNL for patient. Denies any shortness of breath. Water given. DR. informed with order to monitor. At 12:20 patient became nauseated, but it went away after couple of minutes. At 12:15 pm patient c/o tingling and pain to his left arm. At 12:30 pm patient denied any tingling but c/o pain and numbness to his left arm. DR. informed.  Dr evaluated - here in clinic EKG + F/U appt in 1-2 days with physician. Patient  8/16/2021: Pt was taken into exam room EKG performed. Reading to be WN Pt. was c/o chest pain, slight difficulty breathing; numbness in (L) arm, pain in (L) arm; felt that he was slightly dizzy Following EKG patient stated no more chest pain; no difficulty breathing. Was offered option of calling an ambulance for transport to ER - patient declined. Patient was set up for follow-up MD appointment on Wednesday 8/18 and agreed to this plan. EKG attached.
Approximately 10 hours after injection I became tachycardic--on average experienced a heart rate of 100-120 bpm (resting hearting rate is 65-70 bpm) which continued for 6 hours.  This occurred at the same time as fever (highest 99.4 degrees F) and muscular aches in back and legs. After consulting with doctor, I took a combination of ibuprofen and acetaminophen and  half a dose of  metoprolol to lower fever and heart rate.  Experienced a slight headache and had trouble sleeping due to tachycardia.  Tachycardia dissipated 6 hours after onset. All symptoms resolved by 12 PM the next day (approximately 24 hours after injection).
This spontaneous report as received from a healthcare worker refers to a multiple unspecified number of patients of unknown age and gender. There was no information about the patients concurrent conditions, concomitant medications and medical histories reported. On an unknown dates between 02-FEB-2016 and 04-FEB-2016, the patients was vaccinated with an improperly stored doses of GARDASIL 9 (lot# L026602, expiration date 19-OCT-2017; lot# M003659, expiration date 20-SEP-2017, dose, anatomical location and route of administration were not reported). It was also reported that an improperly stored sterile diluent (lot# K023007, expiration date 24-SEP-2017, lot# L017417, expiration date 02-FEB-2018, lot# L015432, expiration date 24-JAN-2018, lot# L03221 and expiration date was not reported; dose, frequency and route of administration were not reported) was used. No adverse events were reported. Temperature 49.3 Fahrenheit degrees (F) for 48 hours, 31.2 F for 16 hours and 16.5 F for 2400 hours. There was no previous temperature excursion and no data logger was involved. This is one of several reports received from the same reporter. Additional information has been requested.
Bells Palsy-seen at ER thinking having stroke-strike protocol tests performed. Still receiving weekly PT-not completely resolved.
On the side where there was an injection the lymph nodes on her neck above her clavicle bone were swollen.  Three could be seen.
Pt recv vax on 12/9/98; on 12/10/98 pt exp rash on stomach, back & LA  Annual follow-up received 11/06/2000. No additional information provided.
spotting, pink colored, as if her period was going to start but it stopped; she had some spotting, pink colored, as if her period was going to start but it stopped; usual side effects; This spontaneous case was reported by a consumer and describes the occurrence of MENSTRUATION DELAYED (spotting, pink colored, as if her period was going to start but it stopped), VACCINATION COMPLICATION (usual side effects) and MENSTRUAL DISORDER (she had some spotting, pink colored, as if her period was going to start but it stopped) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 059H21A) for COVID-19 vaccination.     No Medical History information was reported.   On 08-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .25 ml. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 09-Jan-2022, the patient experienced VACCINATION COMPLICATION (usual side effects). On 11-Jan-2022, the patient experienced MENSTRUATION DELAYED (spotting, pink colored, as if her period was going to start but it stopped) and MENSTRUAL DISORDER (she had some spotting, pink colored, as if her period was going to start but it stopped). On 10-Jan-2022, VACCINATION COMPLICATION (usual side effects) had resolved. On 12-Jan-2022, MENSTRUAL DISORDER (she had some spotting, pink colored, as if her period was going to start but it stopped) had resolved. At the time of the report, MENSTRUATION DELAYED (spotting, pink colored, as if her period was going to start but it stopped) had not resolved.            Concomitant medication was not reported. Treatment information was not reported.
This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 45-year-old male patient received BNT162b2 (BNT162B2), in Sep2021 as dose 3 (booster), single (Batch/Lot number: unknown) for Covid-19 immunisation; CoviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for Covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: DAYQUIL, start date: 09Jun2022, stop date: 13Jun2022. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 2022, outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (Jun2022) negative, notes: Turned negative on a rapid antigen test after 5 days of Paxlovid treatment at day 7. Asymptomatic at day 7. Developed symptoms again at day 10, turned positive on the rapid antigen test again on day 11; (Jun2022) positive, notes: Turned negative on a rapid antigen test after 5 days of Paxlovid treatment at day 7. Asymptomatic at day 7. Developed symptoms again at day 10, turned positive on the rapid antigen test again on day 11. Therapeutic measures were taken as a result of drug ineffective, Covid-19. Clinical course: Other medication details: Other medication in 2 weeks product: Dayquil, Other medication in 2weeks start date: 09Jun2022, Other medication in 2 weeks stop date: 13Jun2022. Turned negative on a rapid antigen test after 5 days of Paxlovid treatment at day 7. Asymptomatic at day 7. Developed symptoms again at day 10, turned positive on the rapid antigen test again on day 11. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
vomiting, weakness, would not get out of bed for 2 days p/ vax;
This is a spontaneous report from a physician. A female patient of an unspecified age started to received PREVNAR (Lot number L77780, expiration date 01Jan2017), via an unspecified route of administration from an unspecified date on 11Aug2015 at 1 DF, single. The patient medical history was not reported. The patient concomitant medications were not reported. The patient experienced allergic reaction to PREVNAR and pruritus on an unspecified date with outcome of unknown. The action taken in response to the event for PREVNAR was not applicable. Follow-up (08Oct2015): This follow-up report is being submitted to amend previously reported information: event coded to allergy to vaccine. Follow0up (30Oct2015): Follow-up attempts completed. No further information expected. Follow-up (25Jan2016): New information received from a contactable physician includes: product data and reaction date (new event added: pruritus. Follow-up attempts completed. No further information expected.
Information has been received from a physician concerning an approximately 60 year old female with type II diabetes mellitus who on approximately 11/07/2005 was vaccinated SQ with a dose of Pneumococcal 23v polysaccharide vaccine (lot #649914/0578P) and a dose of influenza virus vaccine (unspecified) into the opposite arm (unspecified). Concomitant therapy included an unspecified oral therapy. Subsequently the patient developed redness, pain and swelling to the arm that was used for the Pneumococcal 23v polysaccharide vaccination. Medical attention was sought and the patient received diphenhydramine hydrochloride (Benadryl) and prednisone. Subsequently, the patient recovered from redness, pain and swelling to the arm. The physician considered redness, pain and swelling to the arm to be other important medical events (OMIC). Additional information has been requested.